General guidance on management of rheumatology patients during COVID-19 is available from the British Society for Rheumatology. This page gives advice on drug monitoring in…
For a small number of medicines, there are differences in equivalent doses of oral formulations of the same medicine. This Q&A considers which medicines may…
This document is intended to support local discussions on how to monitor commonly prescribed high risk medicines in primary care. Comments have been included as…
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Aminosalicylates for chronic bowel disorders Mesalazine…
Antineoplastic antimetabolites, whether used as monotherapy or in combination with other antineoplastics, are contra-indicated in breastfeeding (except where indicated below) because of their effects on…